|
11 |
P448: Prognostic impact of somatic CEBPA BZIP domain mutations in acute myeloid leukemia
Rücker, Frank Gert. - Freiburg : Universität, 2024
|
|
|
|
12 |
Prognostic value of CPSS cytogenetic risk classification in patients with CMML after allogeneic hematopoietic cell transplantation: a retrospective multicenter study of the Chronic Malignancies Working Party of the EBMT
Könecke, Christian. - Freiburg : Universität, 2022
|
|
|
|
13 |
Molecular landscape and prognostic impact of FLT3-ITD insertion site in acute myeloid leukemia: RATIFY study results
Rücker, Frank Gert. - Ulm : Universität Ulm, 2021
|
|
|
|
14 |
A multicenter prospective, randomized, placebo-controlled phase II/III trial for preemptive acute graft-versus-host disease therapy
Mischak-Weissinger, Eva Maria. - Augsburg : Universität Augsburg, 2020
|
|
|
|
15 |
Allogeneic stem cell transplantation using HLA-matched donors for acute myeloid leukemia with deletion 5q or monosomy 5
Poiré, Xavier. - Freiburg : Universität, 2020
|
|
|
|
16 |
Association of serum ferritin levels before start of conditioning with mortality after alloSCT – a prospective, non-interventional study of the EBMT transplant complications working party
Penack, Olaf. - Freiburg : Universität, 2020
|
|
|
|
17 |
Association of uric acid levels before start of conditioning with mortality after allogeneic hematopoietic stem cell transplantation - a prospective, non-interventional study of the EBMT Transplant Complication Working Party
Penack, Olaf. - Freiburg : Universität, 2020
|
|
|
|
18 |
CAR-T cells targeting Epstein-Barr virus gp350 validated in a humanized mouse model of EBV infection and lymphoproliferative disease
Slabik, Constanze. - Freiburg : Universität, 2020, [Online first]
|
|
|
|
19 |
Inferior outcome of allogeneic stem cell transplantation for secondary acute myeloid leukemia in first complete remission as compared to de novo acute myeloid leukemia
Schmaelter, Ann-Kristin. - Augsburg : Universität Augsburg, 2020
|
|
|
|
20 |
Monosomal karyotype and chromosome 17p loss or TP53 mutations in decitabine-treated patients with acute myeloid leukemia
Becker, Heiko. - Freiburg : Universität, 2020
|
|
Administration
